IBD Stock Of The Day, Boston Scientific, A 'Top Decile' Player, Is Eyeing Two Entries

IBD Stock Of The Day, Boston Scientific, A 'Top Decile' Player, Is Eyeing Two Entries

Boston Scientific is Thursday's IBD Stock Of The Day. Shares are forming a double-bottom base, while approaching an early entry. The post IBD Stock Of The Day, Boston Scientific, A 'Top Decile' Player, Is Eyeing Two Entries appeared first on Investor's Business Daily.

Data backs Boston Scientific drug-eluting stent

The Eluvia drug-eluting stent. [Image courtesy of Boston Scientific]Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD. The company shared multiple new clinical data sets at Charing Cross 2025 in London today. Findings reinforced the growing body of evidence supporting the Eluvia stent for treating peripheral artery disease (PAD) — particularly in the superficial femoral artery (SFA) an…